Folschweiller, N., Teixeira, J., Joshi, S., Goldani, L. Z., Supparatpinyo, K., Basu, P., Chotpitayasunondh, T., Chetchotisakd, P., Ruxrungtham, K., Roteli-Martins, C., Grinsztejn, B., Quintana, S. M., Kumarasamy, N., Poongulali, S., Kulkarni, V., Lin, L., Datta, S. K., Descamps, D., Dodet, M., Dubin, G., Friel, D., Hezareh, M., Karkada, N., Meric Camilleri, D., Poncelet, S., Salaun, B., Tavares-da-Silva, F., Thomas-Jooris, F., & Struyf, F. (2020). immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study. EClinicalMedicine, 23, . http://access.bl.uk/ark:/81055/vdc_100103933838.0x000001